Peptide Receptor Radiotherapy for Neuroendocrine Tumors — Free Webinar on October 20, 2015

Learn more about Peptide Receptor Radionuclide Therapy (PRRT), how it works, where it is being used, and who is eligible for this treatment. Join Josh Mailman, President of NorCal CarciNET; Dr. Edward M. Wolin, Director of Neuroendocrine and GI Oncology and Director of Clinicial Research at the University of Kentucky; and Dr. Erik Mittra, Clinical Assistant Professor, Department of Radiology & Nuclear Medicine at Stanford University in California, on Tuesday, October 20 at 12:00 pm, Eastern Time, for a free webinar.  This webinar is sponsored byNorCal CarciNET and the Society of Nuclear Medicine and Molecular ImagingClick here for the webinar flyer and click here to register.

PRRT Webinar, Oct 20, 2015, Mailman, Wolin, Mittra

Download PDF Version

Print Friendly, PDF & Email